In B16 melanoma model, for instance, intraperitoneal administration of high MW β-glucans facilitates antitumor NK cells and cytotoxic T cell responses against tumor cells by activating DCs through Dectin-1 signaling22,23. The gene discussed is CLEC7A; the disease is neoplasm.